Evidence-based articles on Wegovy, Zepbound, Mounjaro, Ozempic, BMI, BMR, and online telehealth programs. Written to help you lose weight safely.
Answer 5 quick questions to get your personalized weight loss projection with GLP-1 medication.
We'll use this to calculate your personalized weight loss projection.
Which telehealth providers actually offer microdose semaglutide and tirzepatide — NexLife, Telezen, ShedRx, WeightCare, Longevity Direct — and whether the savings justify the evidence gap.
No teaser rates, no dose escalation — TrimRx charges $179/$259 flat with concierge support. Who the premium model serves vs the $69-$125 budget tier.
bmiMD prices semaglutide at $119/mo (12-mo plan) and tirzepatide at $179/mo — solid mid-tier value, minus Louisiana and Mississippi. Where it actually wins.
$199-249/mo for compounded semaglutide is double the budget tier — but WeightCare bundles a coaching app and accepts BMI 20+, one of the lowest thresholds anywhere.
Compounded tirzepatide floor: SnagRx $119 locked, Embody $119 prepay, Trimi $125, NexLife $139 — plus brand Zepbound vials $349 at LillyDirect. The crossover math.
Yucca $146→$206, MEDVi $179→$299, Strut $99 — every GLP-1 intro deal decoded vs real ongoing cost, and the providers with no promo games at all.
The fastest safe rate is 0.5-1% of body weight per week. A science-based plan: calorie targets, protein, steps, and what to expect in the first 2 weeks.
Real 16:8 intermittent fasting results by week — RCT data on weight loss, what the first month actually looks like, and who responds best.
Rapid GLP-1 weight loss changes your face — and the calculus for Botox and fillers. When to treat, what works, and why timing matters.
Massive GLP-1 weight loss leaves loose skin — and a growing plastic surgery demand. Timing, safety, the GLP-1 anesthesia hold, and what surgeons require.
Millions take SSRIs and GLP-1s together. The real interaction picture: absorption timing, weight effects, serotonin syndrome risk, and monitoring.
The microdosing trend: tiny GLP-1 doses for mild appetite suppression without full side effects. What the evidence says and who it might fit.